The EASIX score is associate with overall survival and non-relapse mortality after ex-vivo CD34(+)-selected allogeneic HCT Meeting Abstract


Authors: Sanchez-Escamilla, M.; Hilden, P.; Maloy, M. A.; Fatmi, S.; Giralt, S. A.; Scordo, M.; Perales, M. A.
Abstract Title: The EASIX score is associate with overall survival and non-relapse mortality after ex-vivo CD34(+)-selected allogeneic HCT
Meeting Title: 2019 TCT Meetings of ASBMT and CIBMTR
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 25
Issue: 3 Suppl.
Meeting Dates: 2019 Feb 20-24
Meeting Location: Houston, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2019-03-01
Start Page: S262
Language: English
ACCESSION: WOS:000540655500379
PROVIDER: wos
DOI: 10.1016/j.bbmt.2018.12.267
Notes: Meeting Abstract: 371 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt
  2. Miguel-Angel Perales
    914 Perales
  3. Molly Anna Maloy
    269 Maloy
  4. Michael Scordo
    366 Scordo
  5. Patrick Dale Hilden
    108 Hilden
  6. Samira Anjum Fatmi
    14 Fatmi